Clinical Trial Update: Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating alanyl-glutamine supplementation added to standard treatment for Clostridium difficile infection; study terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Alanyl-glutamine (alanyl-glutamine)

Snippet

Sponsor: University of Virginia | Conditions: Clostridium Difficile Infection | Phase 2 | Status: TERMINATED | Results posted: 2022-06-07